Literature DB >> 19643361

Are there any significant differences between females and males in the management of heart failure? Gender aspects of an elderly population with symptoms associated with heart failure.

Urban Alehagen1, Anne Ericsson, Ulf Dahlström.   

Abstract

BACKGROUND: An increasing interest has been shown in potential gender differences in treating patients with heart failure (HF), a serious condition for the individual. To evaluate whether there are any differences in the prevalence of HF, cardiac function, biomarkers, and the treatment of HF with respect to gender. METHODS AND
RESULTS: All persons ages 70 to 80 in a rural municipality were invited to participate in the project; 876 persons accepted. Three cardiologists evaluated the patients including a new history, clinical examination, electrocardiogram, chest x-ray, blood samples, and Doppler echocardiography to assess both systolic and diastolic function. The patients were followed during a mean period of 8 years.
CONCLUSION: Females had hypertension more frequently and included fewer smokers than their male counterparts. A female preponderance was seen in those with preserved systolic function, whereas males predominated among those with systolic dysfunction. During the follow-up period, 20% of the males and 14% of the females died of cardiovascular diseases. The results did not show any inferior treatment of females with HF, but it clearly was more difficult to correctly classify female patients presenting with symptoms of HF.

Entities:  

Mesh:

Year:  2009        PMID: 19643361     DOI: 10.1016/j.cardfail.2009.01.010

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  3 in total

1.  Understanding and promoting effective self-care during heart failure.

Authors:  Alexander M Clark; Patricia Davidson; Kay Currie; Mehri Karimi; Amanda S Duncan; David R Thompson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

2.  Gender difference in adiponectin associated with cardiovascular mortality.

Authors:  Urban Alehagen; Emina Vorkapic; Liza Ljungberg; Toste Länne; Dick Wågsäter
Journal:  BMC Med Genet       Date:  2015-06-12       Impact factor: 2.103

3.  Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7‑year follow‑up of a healthy community‑living elderly population.

Authors:  Urban Alehagen; Levar Shamoun; Dick Wågsäter
Journal:  Mol Med Rep       Date:  2020-10-01       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.